Cytek Biosciences, Inc. (CTKB) vs VAREX IMAGING (VREX)

Cytek Biosciences, Inc. and VAREX IMAGING are both Medical Devices companies. Cytek Biosciences, Inc. and VAREX IMAGING are of similar size ($784.3M and $744.8M). Cytek Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; VAREX IMAGING trades at 34.8×. Cytek Biosciences, Inc. grew revenue faster over the last twelve months: 5.44% against 5.31%. VAREX IMAGING has the higher net margin (2.55% vs −39.0%) and the higher return on invested capital (5.95% vs −46.4%). Across the 18 metrics below, VAREX IMAGING leads on 12 and Cytek Biosciences, Inc. on 6.

Valuation

Metric CTKB VREX Medical Devices median
P/E n/m 34.81 22.18
P/S 3.56 0.90 2.70
P/B 2.28 1.52 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m 10.15 11.78
EV/Sales 2.29 1.18 2.38
Earnings yield (10.92%) 2.87% (8.22%)
Free cash flow yield (1.63%) (2.60%) (7.80%)

Profitability

Metric CTKB VREX Medical Devices median
Gross margin 53.23% 34.32% 56.01%
Operating margin (21.60%) 8.35% (15.03%)
Net margin (38.98%) 2.55% (20.40%)
Free cash flow margin (5.79%) (2.34%) (7.24%)
Return on equity (23.04%) 4.51% (15.32%)
Return on assets (17.14%) 2.03% (19.72%)
Return on invested capital (46.36%) 5.95% (10.33%)

Growth

Metric CTKB VREX Medical Devices median
Revenue growth (TTM) 5.44% 5.31% 8.80%
EPS growth (last fiscal year) (940.00%) (45.30%) —
Revenue growth, 5-year CAGR 16.76% 2.73% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTKB VREX Medical Devices median
Debt to equity 0.00 0.68 0.07
Current ratio 4.48 3.38 2.50
Net debt to EBITDA 9.19 2.21 0.49

Dividend

Metric CTKB VREX Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric CTKB VREX Medical Devices median
Market cap 744.80m 784.30m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack